Grace Therapeutics (GRCE) Institutional Ownership $2.99 -0.03 (-0.99%) As of 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)CurrentInstitutional OwnershipPercentage6.08%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$4.34MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$575.83K Get GRCE Insider Trade Alerts Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GRCE Institutional Buying and Selling by Quarter Grace Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Millington Financial Advisors LLC20,000$59K0.0%N/A0.145% 7/29/2025AIGH Capital Management LLC1,128,497$3.35M1.5%-14.7%8.160% 7/15/2025Palumbo Wealth Management LLC48,541$144K0.0%N/A0.351% 5/16/2025ADAR1 Capital Management LLC343,512$783K0.1%N/A3.388% 5/15/2025Nantahala Capital Management LLC1,178,203$2.69M0.1%N/A11.619% 5/14/2025Stonepine Capital Management LLC294,550$666K0.6%N/A2.905% (Data available from 1/1/2016 forward) GRCE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GRCE shares? During the previous two years, the following institutional investors and hedge funds held shares of Grace Therapeutics shares: AIGH Capital Management LLC ($3.35M), Nantahala Capital Management LLC ($2.69M), ADAR1 Capital Management LLC ($783K), Stonepine Capital Management LLC ($666K), and Palumbo Wealth Management LLC ($144K), Millington Financial Advisors LLC ($59K).Learn more on Grace Therapeutics' institutional investors. What percentage of Grace Therapeutics' stock is owned by institutional investors? 6.08% of Grace Therapeutics' stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings. Which institutional investors have been buying Grace Therapeutics' stock? The following institutional investors have purchased Grace Therapeutics' stock in the last 24 months: Nantahala Capital Management LLC ($1.18M), ADAR1 Capital Management LLC ($343.51K), Stonepine Capital Management LLC ($294.55K), Palumbo Wealth Management LLC ($48.54K), and Millington Financial Advisors LLC ($20K). How much institutional buying is happening at Grace Therapeutics? Institutional investors have bought a total of 1,884,806 shares in the last 24 months. This purchase volume represents approximately $4.34M in transactions. Which of Grace Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Grace Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($193.88K). How much institutional selling is happening at Grace Therapeutics? Institutional investors have sold a total of 193,882 shares in the last 24 months. This volume of shares sold represents approximately $575.83K in transactions. Related Companies Genelux Major Shareholders Citius Oncology Major Shareholders Actuate Therapeutics Major Shareholders Corbus Pharmaceuticals Major Shareholders Eledon Pharmaceuticals Major Shareholders Theratechnologies Major Shareholders Tevogen Bio Major Shareholders Cassava Sciences Major Shareholders PepGen Major Shareholders Nuvectis Pharma Major Shareholders This page (NASDAQ:GRCE) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
